Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
JAMA Netw Open ; 6(6): e2320796, 2023 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-37378978

RESUMEN

Importance: Institutions and journals strive to promote and protect the integrity of the research record, and both groups are equally committed to ensuring the reliability of all published data. Observations: Three US universities coordinated a series of virtual meetings from June 2021 to March 2022 for a working group composed of senior, experienced US research integrity officers (RIOs), journal editors, and publishing staff who are familiar with managing issues of research integrity and publication ethics. The goal of the working group was to improve the collaboration and transparency between institutions and journals to ensure that research misconduct and publication ethics are managed properly and efficiently. Recommendations address the following: identifying proper contacts at institutions and journals, specifying information to share between institutions and journals, correcting the research record, reconsideration of some fundamental research misconduct concepts, and journal policy changes. The working group identified 3 key recommendations to be adopted and implemented to change the status quo for better collaboration between institutions and journals: (1) reconsideration and broadening of the interpretation by institutions of the need-to-know criteria in federal regulations (ie, confidential or sensitive information and data are not disclosed unless there is a need for an individual to know the facts to perform specific jobs or functions), (2) uncoupling the evaluation of the accuracy and validity of research data from the determination of culpability and intent of the individuals involved, and (3) initiating a widespread change for the policies of journals and publishers regarding the timing and appropriateness for contacting institutions, either before or concurrently under certain conditions, when contacting the authors. Conclusions and Relevance: The working group recommends specific changes to the status quo to enable effective communication between institutions and journals. Using confidentiality clauses and agreements to impede sharing does not benefit the scientific community nor the integrity of the research record. However, a careful and informed framework for improving communications and sharing information between institutions and journals can foster better working relationships, trust, transparency, and most importantly, faster resolution to data integrity issues, especially in published literature.


Asunto(s)
Publicaciones Periódicas como Asunto , Mala Conducta Científica , Humanos , Edición , Reproducibilidad de los Resultados , Confidencialidad
2.
Sci Rep ; 10(1): 16873, 2020 10 09.
Artículo en Inglés | MEDLINE | ID: mdl-33037303

RESUMEN

Tuberculosis (TB) is the leading cause of death due to a single infectious disease. Knowing when a person was infected with Mycobacterium tuberculosis (M.tb) is critical as recent infection is the strongest clinical risk factor for progression to TB disease in immunocompetent individuals. However, time since M.tb infection is challenging to determine in routine clinical practice. To define a biomarker for recent TB exposure, we determined whether gene expression patterns in blood RNA correlated with time since M.tb infection or exposure. First, we found RNA signatures that accurately discriminated early and late time periods after experimental infection in mice and cynomolgus macaques. Next, we found a 6-gene blood RNA signature that identified recently exposed individuals in two independent human cohorts, including adult household contacts of TB cases and adolescents who recently acquired M.tb infection. Our work supports the need for future longitudinal studies of recent TB contacts to determine whether biomarkers of recent infection can provide prognostic information of TB disease risk in individuals and help map recent transmission in communities.


Asunto(s)
Trazado de Contacto/métodos , Mycobacterium tuberculosis/genética , ARN Bacteriano/sangre , Tuberculosis/diagnóstico , Animales , Biomarcadores/sangre , Pruebas Diagnósticas de Rutina , Expresión Génica , Humanos , Macaca , Valor Predictivo de las Pruebas , Riesgo , Tuberculosis/prevención & control , Tuberculosis/transmisión
3.
J Leukoc Biol ; 96(3): 473-80, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24935957

RESUMEN

Systemic inflammation that occurs with increasing age (inflammaging) is thought to contribute to the increased susceptibility of the elderly to several disease states. The elderly are at significant risk for developing pulmonary disorders and infectious diseases, but the contribution of inflammation in the pulmonary environment has received little attention. In this study, we demonstrate that the lungs of old mice have elevated levels of proinflammatory cytokines and a resident population of highly activated pulmonary macrophages that are refractory to further activation by IFN-γ. The impact of this inflammatory state on macrophage function was determined in vitro in response to infection with M.tb. Macrophages from the lungs of old mice secreted more proinflammatory cytokines in response to M.tb infection than similar cells from young mice and also demonstrated enhanced M.tb uptake and P-L fusion. Supplementation of mouse chow with the NSAID ibuprofen led to a reversal of lung and macrophage inflammatory signatures. These data indicate that the pulmonary environment becomes inflammatory with increasing age and that this inflammatory environment can be reversed with ibuprofen.


Asunto(s)
Envejecimiento/inmunología , Citocinas/biosíntesis , Inflamación/inmunología , Pulmón/patología , Macrófagos Alveolares/inmunología , Animales , Antiinflamatorios no Esteroideos/farmacología , Antiinflamatorios no Esteroideos/uso terapéutico , Células Cultivadas , Citocinas/genética , Citocinas/metabolismo , Femenino , Perfilación de la Expresión Génica , Genes Reporteros , Ibuprofeno/farmacología , Ibuprofeno/uso terapéutico , Inflamación/tratamiento farmacológico , Inflamación/patología , Interferón gamma/farmacología , Pulmón/crecimiento & desarrollo , Pulmón/inmunología , Activación de Macrófagos , Macrófagos Alveolares/efectos de los fármacos , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/microbiología , Fusión de Membrana , Ratones , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/inmunología , Fagosomas/fisiología , Fenotipo , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteínas Recombinantes/farmacología , Organismos Libres de Patógenos Específicos
4.
PLoS One ; 8(3): e58612, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23472214

RESUMEN

The exact role of CD8(+) T cells during Mycobacterium tuberculosis (Mtb) infection has been heavily debated, yet it is generally accepted that CD8(+) T cells contribute to protection against Mtb. In this study, however, we show that the Mtb-susceptible CBA/J mouse strain accumulates large numbers of CD8(+) T cells in the lung as infection progresses, and that these cells display a dysfunctional and immunosuppressive phenotype (PD-1(+), Tim-3(+), CD122(+)). CD8(+) T cell expansions from the lungs of Mtb-infected CBA/J mice were also capable of secreting the immunosuppressive cytokine interleukin-10 (IL-10), although in vivo CD8(+) T cell depletion did not significantly alter Mtb burden. Further analysis revealed that pulmonary CD8(+) T cells from Mtb-infected CBA/J mice were clonally expanded, preferentially expressing T cell receptor (TcR) Vß chain 8 (8.2, 8.3) or Vß 14. Although Vß8(+) CD8(+) T cells were responsible for the majority of IL-10 production, in vivo depletion of Vß8(+) did not significantly change the outcome of Mtb infection, which we hypothesize was a consequence of their dual IL-10/IFN-γ secreting profiles. Our data demonstrate that IL-10-secreting CD8(+) T cells can arise during chronic Mtb infection, although the significance of this T cell population in tuberculosis pathogenesis remains unclear.


Asunto(s)
Linfocitos T CD8-positivos/citología , Interleucina-10/metabolismo , Tuberculosis/inmunología , Tuberculosis/microbiología , Animales , Linfocitos T CD8-positivos/inmunología , Femenino , Citometría de Flujo , Predisposición Genética a la Enfermedad , Tolerancia Inmunológica , Activación de Linfocitos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Mycobacterium tuberculosis , Fenotipo , Receptores de Antígenos de Linfocitos T/genética
5.
J Immunol ; 190(6): 2778-90, 2013 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-23396944

RESUMEN

Protective immunity and latent Mycobacterium tuberculosis infection in humans are associated with the formation of mature protective granulomas within the lung. Unfortunately, understanding the importance of such structures has been hindered by the lack of small-animal models that can develop mature granulomas. In this article, we describe for the first time, to our knowledge, the formation of mature, fibrotic M. tuberculosis-containing pulmonary granulomas in a mouse model of IL-10 deficiency (CBA/J IL-10(-/-)). Long-term control of M. tuberculosis infection in the absence of IL-10 was also associated with an early and enhanced capacity for Ag presentation and a significant increase in the generation of multifunctional T cells. Although IL-10 deficiency is known to enhance Th1 immune responses in general, we demonstrate in this study using transient anti-IL-10R treatment that it is the presence of IL-10 in vivo during the first month of M. tuberculosis infection that plays a definitive role in the inhibition of optimum protective immunity that can establish the environment for mature granuloma formation. Although the importance of IL-10 during M. tuberculosis infection has been debated, our data demonstrate that in CBA/J mice, IL-10 plays a significant early inhibitory role in preventing the development of protective immunity associated with containment of M. tuberculosis infection.


Asunto(s)
Granuloma del Sistema Respiratorio/inmunología , Granuloma del Sistema Respiratorio/prevención & control , Interleucina-10/fisiología , Mycobacterium tuberculosis/inmunología , Tuberculosis Pulmonar/inmunología , Tuberculosis Pulmonar/prevención & control , Animales , Carga Bacteriana , Modelos Animales de Enfermedad , Fibrosis/prevención & control , Granuloma del Sistema Respiratorio/microbiología , Interleucina-10/deficiencia , Interleucina-10/genética , Pulmón/inmunología , Pulmón/microbiología , Pulmón/patología , Ganglios Linfáticos/inmunología , Ganglios Linfáticos/microbiología , Ganglios Linfáticos/patología , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos CBA , Ratones Noqueados , Bazo/inmunología , Bazo/microbiología , Bazo/patología , Tuberculosis Pulmonar/microbiología
6.
Infect Immun ; 81(4): 1090-9, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23340310

RESUMEN

The expression of T cell differentiation markers is known to increase during Mycobacterium tuberculosis infection, and yet the biological role of such markers remains unclear. We examined the requirement of the T cell differentiation marker killer cell lectin-like receptor G1 (KLRG1) during M. tuberculosis infection using mice deficient in KLRG1. KLRG1(-/-) mice had a significant survival extension after M. tuberculosis infection compared to wild-type controls, and maintained a significantly lower level of pulmonary M. tuberculosis throughout chronic infection. Improved control of M. tuberculosis infection was associated with an increased number of activated pulmonary CD4(+) T cells capable of secreting gamma interferon (IFN-γ). Our report is the first to show an in vivo impact of KLRG1 on disease control.


Asunto(s)
Mycobacterium tuberculosis/patogenicidad , Receptores Inmunológicos/metabolismo , Tuberculosis/patología , Animales , Carga Bacteriana , Linfocitos T CD4-Positivos/inmunología , Interferón gamma/metabolismo , Lectinas Tipo C , Pulmón/microbiología , Pulmón/patología , Ratones , Ratones Noqueados , Mycobacterium tuberculosis/inmunología , Receptores Inmunológicos/deficiencia , Análisis de Supervivencia , Tuberculosis/inmunología , Tuberculosis/mortalidad
7.
J Clin Microbiol ; 50(7): 2469-71, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22518862

RESUMEN

We compared the performance of the T-SPOT.TB assay with blood used within 0 to 3.5 h after collection (control) to its performance with blood stored for 0 to 3.5, 5 to 8, 18 to 21, or 31 to 33 h with the addition of T-Cell Xtend (experimental), using samples from 154 participants. The 95.4% concordance between paired specimens indicated that blood can be stored for up to 33 h prior to T-SPOT.TB testing.


Asunto(s)
Sangre/inmunología , Ensayos de Liberación de Interferón gamma/métodos , Manejo de Especímenes/métodos , Tuberculosis/diagnóstico , Adulto , Femenino , Humanos , Indicadores y Reactivos/química , Masculino , Persona de Mediana Edad , Factores de Tiempo , Tuberculosis/microbiología
8.
Eur J Immunol ; 42(4): 870-9, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22531914

RESUMEN

In CBA/J mice, susceptibility to Mycobacterium tuberculosis (M.tb) is associated with low interferon-gamma (IFN-γ) responses to antigens (Antigen 85 (Ag85) and early secreted antigenic target-6 (ESAT-6)) that have been defined as immunodominant. Here, we asked whether the failure of CBA/J mice to recognize Ag85 is a consequence of M.tb infection or whether CBA/J mice have a general defect in generating specific T-cell responses to this protein antigen. We compared CBA/J mice during primary M.tb infection, Ag85 vaccination followed by M.tb challenge, or M.tb memory immune mice for their capacity to generate Ag85-specific IFN-γ responses and to control M.tb infection. CBA/J mice did not respond efficiently to Ag85 in the context of natural infection or re-infection. In contrast, CBA/J mice could generate Ag85-specific IFN-γ responses and protective immunity when this antigen was delivered as a soluble protein. Our data indicate that although M.tb infection of CBA/J mice does not drive an Ag85 response, these mice can fully and protectively respond to Ag85 if it is delivered as a vaccine. The data from this experimental model suggest that the Ag85-containing vaccines in clinical trials should protect M.tb susceptible humans.


Asunto(s)
Antígenos Bacterianos/farmacología , Memoria Inmunológica/efectos de los fármacos , Mycobacterium tuberculosis/inmunología , Linfocitos T/inmunología , Tuberculosis/inmunología , Tuberculosis/prevención & control , Animales , Antígenos Bacterianos/inmunología , Modelos Animales de Enfermedad , Humanos , Interferón gamma/inmunología , Ratones , Vacunación
9.
Cell Immunol ; 271(1): 53-61, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21714962

RESUMEN

The in vitro immune responses to mycobacterial antigens have been linked to the H-2 loci in mice. We evaluated in vitro and in vivo immune responses during early Mycobacterium tuberculosis (M.tb) pulmonary infection of C57BL/6 (H-2(b)), C57BL/6 (H-2(k)), CBA/J (H-2(k)), and C3H/HeJ (H-2(k)) mice to determine H-2(k)-dependent and -independent effects. H-2(k)-dependent effects included delayed and diminished Ag85-specific Th1 cell priming, a reduced frequency of Ag85-specific IFN-γ producing cells, reduced IFN-γ protein in vivo, and increased M.tb lung burden as demonstrated by C57BL/6 H-2(k) mice vs. C57BL/6 mice. H-2(k)-independent factors controlled the amount of Ag85-specific IFN-γ produced by each cell, T cell numbers, granuloma size, and lymphocytic infiltrates in the lungs. Overall, these results suggest that an H-2(k)-dependent suboptimal generation of Ag85-specific cells impairs control of early M.tb growth in the lungs. H-2(k)-independent factors influence the potency of IFN-γ producing cells and immune cell trafficking during pulmonary M.tb infection.


Asunto(s)
Aciltransferasas/inmunología , Antígenos Bacterianos/inmunología , Antígenos H-2/inmunología , Interferón gamma/inmunología , Mycobacterium tuberculosis/inmunología , Tuberculosis Pulmonar/inmunología , Alelos , Animales , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Antígenos H-2/genética , Haplotipos , Interacciones Huésped-Patógeno/inmunología , Interferón gamma/metabolismo , Pulmón/inmunología , Pulmón/metabolismo , Pulmón/microbiología , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Mycobacterium tuberculosis/fisiología , Tuberculosis Pulmonar/metabolismo , Tuberculosis Pulmonar/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...